Graves’ disease as a manifestation of immune reconstitution inflammatory syndrome in an HIV-1-infected adolescent patient: A case report

Liga Kornete1, Ruta Terauda1, Sintija Sausa2, Iveta Dzivite-Krisane3, Ivars Melderis4, Valentina Sitkare5, Baiba Rozentale5, Davis Rudolfs Zakis6
1Faculty of Medicine, Riga Stradins University, Riga, Latvia
2Faculty of Medicine, University of Latvia, Riga, Latvia
3Children's Clinical University Hospital and Riga Stradins University, Riga, Latvia, and Endo-ERN Latvia
4Department of Pathology, Children's Clinical University Hospital, Riga, Latvia
5Outpatient Department of the Latvian Centre of Infectious Diseases, Riga East Clinical University Hospital, and Riga Stradins University Riga, Latvia
6Department of Conservative Dentistry and Oral Health, Faculty of Dentistry, Riga Stradins University, Riga, Latvia

Tài liệu tham khảo

Rabon, 2016, Graves' disease in children: long-term outcomes of medical therapy, Clin Endocrinol (Oxf), 85, 632, 10.1111/cen.13099 Kaplowitz, 2020, Update on pediatric hyperthyroidism, Curr Opin Endocrinol Diabetes Obes, 27, 70, 10.1097/MED.0000000000000521 Williamson, 2010, Incidence of thyrotoxicosis in childhood: a national population based study in the UK and Ireland, Clin Endocrinol (Oxf), 72, 358, 10.1111/j.1365-2265.2009.03717.x Simon, 2018, Epidemiology of childhood hyperthyroidism in France: a nationwide population-based study, J Clin Endocrinol Metab, 103, 2980, 10.1210/jc.2018-00273 Havgaard Kjær, 2015, Increasing incidence of juvenile thyrotoxicosis in Denmark: a nationwide study, 1998-2012, Horm Res Paediatr, 84, 102, 10.1159/000430985 De Luca, 2018, Controversies in the pharmacological treatment of Graves' disease in children, Expet Rev Clin Pharmacol, 11, 1113, 10.1080/17512433.2018.1546576 Minamitani, 2017, Guidelines for the treatment of childhood-onset Graves' disease in Japan, 2016, Clin Pediatr Endocrinol Case Reports Clin Investig Off J Japanese Soc Pediatr Endocrinol, 26, 29 Müller, 2010, Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis, Lancet Infect Dis, 10, 251, 10.1016/S1473-3099(10)70026-8 Dhasmana, 2008, Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management, Drugs, 68, 191, 10.2165/00003495-200868020-00004 Pérez, 2009, Graves' disease following successful HAART of a perinatallyHIV-infected 11-year-old, AIDS, 23, 645, 10.1097/QAD.0b013e32832407e2 Katusiime, 2018, Graves ’ disease - immune reconstitution inflammatory syndrome in an HIV-1 infected patient: the first documented report in africa and a systematic literature review of autoimmune immune reconstitution inflammatory, Syndromes, 1, 50 Rasul, 2011, Graves' disease as a manifestation of immune reconstitution in HIV-infected individuals after initiation of highly active antiretroviral therapy, AIDS Res Treat, 2011 Višković, 2013, Repeated presentation of graves' disease as a manifestation of immune reconstitution syndrome in an HIV-infected patient taking HAART: case report, Acta Clin Croat, 52, 125 Muller, 2019, 2019 European thyroid association guidelines on the management of thyroid dysfunction following immune reconstitution therapy, Eur Thyroid J, 8, 173, 10.1159/000500881 Ibrahim, 2019, Thyroid function in individuals living with human immunodeficiency virus: the concern and debate about regular screening, Ann Thyroid, 4, 12, 10.21037/aot.2019.07.01 Beatty, 2010, Immune reconstitution inflammatory syndrome, Emerg Med Clin, 28, 393, 10.1016/j.emc.2010.01.004